skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

33 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Podcast: Significant Approvals, Diabetes and NASH In India, Japan M&A

18 Dec 2019

Join the Asia-based content team for Scrip and the Pink Sheet for their first podcast as they take a look at some of the most significant regional pharma stories of the past few weeks.

Topic drug-approval business-strategies

awareness, Datamonitor Healthcare: 医療用医薬品の市場調...

Post-ESMO Podcast 2019

31 Oct 2019

Post-ESMO Podcast 2019

Listen to this podcast to keep up with the latest translational science and advancements in oncology to come out of the European Society of Medical Oncology (ESMO) Congress 2019. Datmonitor Healthcare’s post-event podcast delivers every important development.

Topic cancer research

awareness

Global Generics Podcast 2018

22 Aug 2018

Global Generics Podcast 2018

Listen to this podcast with Generics bulletin editor Aidan Fry and deputy editor David Wallace. The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted.

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Podcast - Analyst Opinion on Approval of AndexXa for reversal of Eliquis and Xarelto

22 Aug 2018

Podcast - Analyst Opinion on Approval of AndexXa for reversal of Eliquis and Xarelto

Zach McLellan, Jack Allen, and guest analyst Cameron Findlater discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of AndexXa for reversal of Eliquis and Xarelto & Eli Lilly's acquisition of ARMO Biosciences.

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 2

22 Aug 2018

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 2

Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 1

22 Aug 2018

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 1

Zach McLellan and Jack Allen are joined by guest analysts Dominique Fontanilla and Hardik Patel. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Approval of Sun Pharmas Yonsa in Prostate Cancer Podcast

29 May 2018

Approval of Sun Pharmas Yonsa in Prostate Cancer Podcast

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of Sun Pharma's Yonsa in prostate cancer, and broad market commentary on Tesaro, Gilead, Clovis, Portola, BMS and Celgene

Topic company-analysis

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Datamonitor Healthcare Podcast 16 February 2018

15 May 2018

Datamonitor Healthcare Podcast 16 February 2018

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including a recap of the 2018 BIO CEO conference, Phase IIb results of aramchol in HIV-lipodystrophy NAFLD or NASH patients, and the approval of Ereleada (apalutamide) in non-metastatic castration-resistant prostate cancer.

Topic business-strategies biopharmaceutical

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Datamonitor Healthcare Podcast 04 April 2018

15 May 2018

Datamonitor Healthcare Podcast 04 April 2018

Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.

Topic drug-development-landscape

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。